Cas:105391-33-1 Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane manufacturer & supplier

Chemical Name:Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane

CAS.NO:105391-33-1

Synonyms:1,1′-[Methylenebis(2-ethyl-6-methyl-4,1-phenylene)]bis(1H-pyrrole-2,5-dione);Bis(3-ethyl-5-Methyl-4-MaleiMidophenyl)Methane;1H-Pyrrole-2,5-dione, 1,1′-[methylenebis(2-ethyl-6-methyl-4,1-phenylene)]bis-;1-[4-[[4-(2,5-dioxopyrrol-1-yl)-3-ethyl-5-methylphenyl]methyl]-2-ethyl-6-methylphenyl]pyrrole-2,5-dione

Molecular Formula:C₂₇H₂₆N₂O₄

Molecular Weight:442.506

HS Code:

Physical and Chemical Properties:

Melting point:165ºC

Boiling point:618.7±55.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.633

PSA:74.76000

Exact Mass:442.189270

LogP:4.85

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1′-[Methylenebis(2-ethyl-6-methyl-4,1-phenylene)]bis(1H-pyrrole-2,5-dione) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[4-[[4-(2,5-dioxopyrrol-1-yl)-3-ethyl-5-methylphenyl]methyl]-2-ethyl-6-methylphenyl]pyrrole-2,5-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[4-[[4-(2,5-dioxopyrrol-1-yl)-3-ethyl-5-methylphenyl]methyl]-2-ethyl-6-methylphenyl]pyrrole-2,5-dione Use and application,1,1′-[Methylenebis(2-ethyl-6-methyl-4,1-phenylene)]bis(1H-pyrrole-2,5-dione) technical grade,usp/ep/jp grade.

Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane manufacturer On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane supplier The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane factory On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration.